Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention

References

• Brewer BG, Mitchell RA, Harandi A, Eaton JW. Embryonic vaccines against cancer: an early history. Exp Mol Pathol. 2009;86:192–197. doi:10.1016/j.yexmp.2008.12.002.
   PubMed Web of Science ®Google Scholar
• Stonehill EH, Bendich A. Retrogenetic expression: the reappearance of embryonal antigens in cancer cells. Nature. 1970;228:370–372.
   PubMed Web of Science ®Google Scholar
• Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499–507. doi:10.1038/ng.127.
   PubMed Web of Science ®Google Scholar
• Yaddanapudi K, Mitchell RA, Putty K, Willer S, Sharma RK, Yan J, Bodduluri H, Eaton JW, Gabriele L. Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible? PLoS One. 2012;7:e42289. doi:10.1371/journal.pone.0042289.
   PubMed Web of Science ®Google Scholar
• Kooreman NG, Kim Y, de Almeida PE, Termglinchan V, Diecke S, Shao NY, Wei -T-T, Yi H, Dey D, Nelakanti R, et al. Autologous iPSC-Based vaccines elicit anti-tumor responses in vivo. Cell Stem Cell. 2018;22:501–13 e7. doi:10.1016/j.stem.2018.01.016.
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289. doi:10.1146/annurev-cellbio-101512-122326.
   PubMed Web of Science ®Google Scholar
• Gehrmann U, Naslund TI, Hiltbrunner S, Larssen P, Gabrielsson S. Harnessing the exosome-induced immune response for cancer immunotherapy. Semin Cancer Biol. 2014;28:58–67. doi:10.1016/j.semcancer.2014.05.003.
   PubMed Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–579. doi:10.1038/nri855.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–659. doi:10.1038/ncb1596.
   PubMed Web of Science ®Google Scholar
• Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. doi:10.3402/jev.v4.27066.
   PubMed Web of Science ®Google Scholar
• Lener T, Gimona M, Aigner L, Borger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Portillo HAD, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087. doi:10.3402/jev.v4.30087.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzas EI, Bemis LT, Bora A, Lasser C, Lotvall J, Nolte-‘t Hoen EN, Piper MG, Sivaraman S, Skog J. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2(1). doi: 10.3402/jev.v2i0.20360. eCollection 2013.
   Google Scholar
• Armstrong JP, Holme MN, Stevens MM. Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano. 2017;11:69–83. doi:10.1021/acsnano.6b07607.
   PubMed Web of Science ®Google Scholar
• Schlesinger S, Lee AH, Wang GZ, Green L, Goff SP. Proviral silencing in embryonic cells is regulated by Yin Yang 1. Cell Rep. 2013;4:50–58. doi:10.1016/j.celrep.2013.06.003.
   PubMed Web of Science ®Google Scholar
• Chung S, Andersson T, Sonntag KC, Bjorklund L, Isacson O, Kim KS. Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells. 2002;20:139–145. doi:10.1634/stemcells.20-2-139.
   PubMed Web of Science ®Google Scholar
• Zeng X, Chen J, Sanchez JF, Coggiano M, Dillon-Carter O, Petersen J, Freed WJ. Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells. 2003;21:647–653. doi:10.1634/stemcells.21-6-647.
   PubMed Web of Science ®Google Scholar
• Herbst B, Kohler G, Mackensen A, Veelken H, Lindemann A. GM-CSF promotes differentiation of a precursor cell of monocytes and Langerhans-type dendritic cells from CD34+ haemopoietic progenitor cells. Br J Haematol. 1998;101:231–241.
   PubMed Web of Science ®Google Scholar
• Zhao W, Ji X, Zhang F, Li L, Ma L. Embryonic stem cell markers. Molecules. 2012;17:6196–6236. doi:10.3390/molecules17066196.
   PubMed Web of Science ®Google Scholar
• Bosch S, de Beaurepaire L, Allard M, Mosser M, Heichette C, Chretien D, Jegou D, Bach J-M. Trehalose prevents aggregation of exosomes and cryodamage. Sci Rep. 2016;6:36162. doi:10.1038/srep36162.
   PubMed Web of Science ®Google Scholar
• Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Théry C. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113:E968–977. doi:10.1073/pnas.1521230113.
   PubMed Web of Science ®Google Scholar
• Mignot G, Roux S, Thery C, Segura E, Zitvogel L. Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med. 2006;10:376–388.
   PubMed Web of Science ®Google Scholar
• Gutschner T, Hammerle M, Pazaitis N, Bley N, Fiskin E, Uckelmann H, Heim A, Groβ M, Hofmann N, Geffers R, et al. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma. Hepatology. 2014;59:1900–1911. doi:10.1002/hep.26997.
   PubMed Web of Science ®Google Scholar
• Patriarca C, Macchi RM, Marschner AK, Mellstedt H. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat Rev. 2012;38:68–75. doi:10.1016/j.ctrv.2011.04.002.
   PubMed Web of Science ®Google Scholar
• Glas AS, Roos D, Deutekom M, Zwinderman AH, Bossuyt PM, Kurth KH. Tumor markers in the diagnosis of primary bladder cancer. A Systematic Review J Urol. 2003;169:1975–1982.
   PubMed Web of Science ®Google Scholar
• Kornberg A, Polliack A. Serum lactic dehydrogenase (LDH) levels in acute leukemia: marked elevations in lymphoblastic leukemia. Blood. 1980;56:351–355.
   PubMed Web of Science ®Google Scholar
• Baldwin RW, Glaves D, Vose BM. Embryonic antigen expression in chemically induced rat hepatomas and sarcomas. Int J Cancer. 1972;10:233–243.
   PubMed Web of Science ®Google Scholar
• Baldwin RW, Glaves D, Pimm MV, Vose BM. Tumour specific and embryonic antigen expression of chemically induced rat tumours. Ann Inst Pasteur (Paris). 1972;122:715–728.
   PubMedGoogle Scholar
• Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006;6:295–307. doi:10.1038/nri1806.
   PubMed Web of Science ®Google Scholar
• Ortiz ML, Lu L, Ramachandran I, Gabrilovich DI. Myeloid-derived suppressor cells in the development of lung cancer. Cancer Immunol Res. 2014;2:50–58. doi:10.1158/2326-6066.CIR-13-0129.
   PubMed Web of Science ®Google Scholar
• Chesney JA, Mitchell RA, Yaddanapudi K. Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. J Leukoc Biol. 2017;102:727–740. doi:10.1189/jlb.5VMR1116-458RRR.
   PubMed Web of Science ®Google Scholar
• Morales JK, Kmieciak M, Knutson KL, Bear HD, Manjili MH. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res Treat. 2010;123:39–49. doi:10.1007/s10549-009-0622-8.
   PubMed Web of Science ®Google Scholar
• Filipazzi P, Valenti R, Huber V, Pilla L, Canese P, Iero M, Castelli C, Mariani L, Parmiani G, Rivoltini L. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol. 2007;25:2546–2553. doi:10.1200/JCO.2006.08.5829.
   PubMed Web of Science ®Google Scholar
• Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, Abe J, Shono Y, Kitabatake M, Kakimi K, Mukaida N, et al. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood. 2008;111:5457–5466. doi:10.1182/blood-2008-01-136895.
   PubMed Web of Science ®Google Scholar
• Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, Gmeiner M, Campo JJ, Esen M, Ruben AJ, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445–449. doi:10.1038/nature21060.
   PubMed Web of Science ®Google Scholar
• Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411–422. doi:10.1056/NEJMoa1001294.
   PubMed Web of Science ®Google Scholar
• Li Y, Zeng H, Xu RH, Liu B, Li Z. Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer. Stem Cells. 2009;27:3103–3111. doi:10.1002/stem.234.
   PubMed Web of Science ®Google Scholar
• Dong W, Du J, Shen H, Gao D, Li Z, Wang G, Mu X, Liu Q. Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load. Cancer Immunol Immunother. 2010;59:1697–1705. doi:10.1007/s00262-010-0899-9.
   PubMed Web of Science ®Google Scholar
• Palena C, Abrams SI, Schlom J, Hodge JW. Cancer vaccines: preclinical studies and novel strategies. Adv Cancer Res. 2006;95:115–145. doi:10.1016/S0065-230X(06)95004-0.
   PubMed Web of Science ®Google Scholar
• Dranoff G. GM-CSF-based cancer vaccines. Immunol Rev. 2002;188:147–154.
   PubMed Web of Science ®Google Scholar
• Bencherif SA, Warren Sands R, Ali OA, Li WA, Lewin SA, Braschler TM, Shih T-Y, Verbeke CS, Bhatta D, Dranoff G, et al. Injectable cryogel-based whole-cell cancer vaccines. Nat Commun. 2015;6:7556. doi:10.1038/ncomms8556.
   PubMed Web of Science ®Google Scholar
• Kunigelis KE, Graner MW. The dichotomy of tumor exosomes (TEX) in cancer immunity: is it all in the conTEXt? Vaccines (Basel). 2015;3:1019–1051. doi:10.3390/vaccines3041019.
   PubMed Web of Science ®Google Scholar
• Borrello I, Pardoll D. GM-CSF-based cellular vaccines: a review of the clinical experience. Cytokine Growth Factor Rev. 2002;13:185–193.
   PubMed Web of Science ®Google Scholar
• Soiffer R, Hodi FS, Haluska F, Jung K, Gillessen S, Singer S, Tanabe K, Duda R, Mentzer S, Jaklitsch M, et al. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma. J Clin Oncol. 2003;21:3343–3350. doi:10.1200/JCO.2003.07.005.
   PubMed Web of Science ®Google Scholar
• Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, Raposo G, Amigorena S. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol. 1999;147:599–610.
   PubMed Web of Science ®Google Scholar
• Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161–1172.
   PubMed Web of Science ®Google Scholar
• Viaud S, Terme M, Flament C, Taieb J, Andre F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One. 2009;4:e4942. doi:10.1371/journal.pone.0004942.3
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4:594–600.
   PubMed Web of Science ®Google Scholar
• Mazumder S, Johnson JM, Swank V, Dvorina N, Martelli E, Ko J, Tuohy VK. Primary immunoprevention of epithelial ovarian carcinoma by vaccination against the extracellular domain of anti-mullerian hormone receptor II. Cancer Prev Res (Phila). 2017;10:612–624. doi:10.1158/1940-6207.CAPR-17-0154.
   PubMed Web of Science ®Google Scholar
• Shoemaker RH, Forsthuber TG. Targeting “retired antigens” for cancer immunoprevention. Cancer Prev Res (Phila). 2017;10:607–608. doi:10.1158/1940-6207.CAPR-17-0188.
   PubMed Web of Science ®Google Scholar
• Jaini R, Kesaraju P, Johnson JM, Altuntas CZ, Jane-Wit D, Tuohy VK. An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med. 2010;16:799–803. doi:10.1038/nm.2161.
   PubMed Web of Science ®Google Scholar